Intended Use

The ClearPoint System is intended to provide stereotactic guidance for the placement and operation of instruments or devices during planning and operation of neurological procedures within an operating room environment and in conjunction with MR and/or CT imaging. It also provides functionality for automatic identification, labeling, visualization, and quantification of segmentable brain structures from loaded MR images.

Technology

ClearPoint System 3.0 includes software modifications to support intraoperative CT imaging workflow in addition to MR imaging. It features automatic segmentation of hardware components from CT images, enhanced image fusion and registration tools, and clinical workflow improvements post device insertion. It integrates stereotactic guidance with a hardware platform consisting of adjustable frames and accessories providing trajectory guidance during neurosurgical procedures.

Performance

Extensive non-clinical verification and validation were performed, including automated verification, integrated system verification with MR imaging, regression testing, manual testing, and accuracy verification using CT imaging. Testing demonstrated positional and angular accuracy within clinically acceptable ranges, confirming the system's safety and effectiveness for MR- and CT-guided neurosurgical procedures.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    11/27/2024

    1 month
  • 2

    FDA Approval

    1/24/2025

Other devices from ClearPoint Neuro, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.